Takeda Declines to Exercise Option for Wave's WVE-003
ViiV Healthcare, Owned By GSK, Pfizer And Shionogi, Announced The Presentation Of New Real-world Evidence And Implementation Data Showing The Effectiveness, Adherence, And Quality-of-life Improvement Of Apretude (Cabotegravir Long-acting) For HIV...
The FDA Has Accepted Us Marketing Application For GSK's Gepotidacin, An Oral Antibiotic For Adult And Adolescent Females For Uncomplicated Urinary Tract Infections, 26 March 2025 Assigned As Action Date For FDA Decision
GSK's UTI Treatment Gets Accepted for Priority Review by U.S.'s FDA
glaxosmithkline sues Moderna for infringing its patent rights on the COVID-19 vaccine.
GlaxoSmithKline October 15th | GlaxoSmithKline filed a lawsuit against Moderna in the Federal Court of Delaware on Tuesday, alleging that Moderna's COVID-19 vaccine Spikevax infringed on its patents in mRNA technology. The company filed a similar lawsuit against Pfizer and biontech in the same court in April this year.
Express News | Glaxosmithkline Sues Moderna for U.S. Patent Infringement Over Mrna Technology in Covid-19 Vaccines - Court Filing